Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy for patients compromised pulmonary function. The Company's proprietary system generates High Frequency Chest Wall Oscillation ("HFCWO"), a technique for airway clearance therapy, also known as High Frequency Chest Compression.

Current Report (Form 8-K | Period ending 2024-11-15)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Electromed (ELMD US)

Current Report (Form 8-K | Period ending 2024-11-15)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-12)

Annual Report to Security Holders (Form ARS | Period ending 2024-06-30)

Current Report (Form 8-K | Period ending 2024-09-11)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)